Agent Trial
Trading Prediction Markets AI Agent Context Fastest News API Agent Trial Log In Sign Up
News Wire / health

Primidone Tablets Recalled By Golden State Medical

developing OpenFDA United States 54m9m Impact 5
Zydus Pharmaceuticals (USA) Inc. has initiated a Class II ongoing recall for Erythromycin Tablets, USP, 250 mg. The tablets are packaged in bottles of 30 and are for prescription use. has initiated a Class III recall for Primidone Tablets, USP, 50 mg, 50-count bottles.

Topics

drug recall pharmaceuticals

Developing

  1. 882d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 882d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 882d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 882d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

OpenFDA

“FDA Drug Recall: Zydus Pharmaceuticals (USA) Inc. FDA Drug Recall: Zydus Pharmaceuticals (USA) Inc | Class Class II | Status: Ongoing | Product: Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifescienc”

OpenFDA

“FDA Drug Recall: Golden State Medical Supply Inc.. FDA Drug Recall: Golden State Medical Supply Inc. | Class Class III | Status: Ongoing | Product: Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Mar”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade